Laboratories Inc

Rediff.com » News » Laboratories Inc

News for Laboratories Inc

News
Business
Sports

Covaxin booster can neutralise Omicron, Delta variants: Bharat Biotech

Bharat Biotech on Wednesday said a study has demonstrated that a booster dose of Covaxin has a neutralising effect on the Omicron and Delta variants of COVID-19. Image used for representational......

Govt approves 2 new vaccines, Covid drug for emergency use

Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drugs Standard Control Organisation (CDSCO) has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological......

Moderna's single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 cr doses for 2021

Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots......

COVID-19 second wave: Delays in RT-PCR tests

While there is a shortage of testing kits, manpower and capacities, India does not have other scalable testing options, report Vinay Umarji and Sohini Das. IMAGE: A medical worker collects the......

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with......

BSE 100 companies boost R&D, innovation challenges persist

Research and development (R&D) spending by BSE 100 companies has grown steadily, rising from 0.89 per cent of revenue in FY20 to 1.32 per cent in FY24, averaging around 1 per cent over the period......

Q3 result preview: US, India to aid revenue growth for Pharma Inc

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for......

2 Dabur cos get relief in multiple lawsuits in US court

In a relief to FMCG major Dabur, two of its foreign subsidiaries, Dabur International and Dermoviva Skin Essentials, have been removed as a defendant in multiple lawsuits filed in a US court over......

'Sun Pharma offers the best medium- to long-term earnings growth visibility'

India’s largest listed pharmaceutical (pharma) company — Sun Pharmaceutical Industries (Sun Pharma) — is expected to maintain its outperformance vis-à-vis the......

Sun Pharma recalls over 34k bottles of generic drug in US

Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing. Photograph: Francis......

Top doctor says Japan must keep state of emergency

'Without vaccine, Tokyo Olympics in 2021 is difficult' IMAGE: The Tokyo Games were postponed until 2021 last week as the coronavirus outbreak deepened, an unprecedented move in the 124-year......

Rediff News

Laboratories Inc

News for Laboratories Inc

Covaxin booster can neutralise Omicron, Delta variants: Bharat Biotech

Govt approves 2 new vaccines, Covid drug for emergency use

Moderna's single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 cr doses for 2021

COVID-19 second wave: Delays in RT-PCR tests

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

BSE 100 companies boost R&D, innovation challenges persist

Q3 result preview: US, India to aid revenue growth for Pharma Inc

2 Dabur cos get relief in multiple lawsuits in US court

'Sun Pharma offers the best medium- to long-term earnings growth visibility'

Sun Pharma recalls over 34k bottles of generic drug in US

Top doctor says Japan must keep state of emergency

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS